Importer of Controlled Substances Registration, 14913-14914 [2017-05730]

Download as PDF 14913 Federal Register / Vol. 82, No. 55 / Thursday, March 23, 2017 / Notices INTERNATIONAL TRADE COMMISSION [USITC SE–17–012] Government in the Sunshine Act Meeting Notice United States International Trade Commission. TIME AND DATE: March 30, 2017 at 11:00 a.m. PLACE: Room 101, 500 E Street SW., Washington, DC 20436, Telephone: (202) 205–2000. STATUS: Open to the public. AGENCY HOLDING THE MEETING: Matters To Be Considered 1. Agendas for future meetings: None. 2. Minutes. 3. Ratification List. 4. Vote in Inv. No. 731–TA–1314 (Final) (Phosphor Copper from Korea). The Commission is currently scheduled to complete and file its determination and views of the Commission by April 17, 2017. 5. Outstanding action jackets: None. In accordance with Commission policy, subject matter listed above, not disposed of at the scheduled meeting, may be carried over to the agenda of the following meeting. By order of the Commission. Issued: March 21, 2017. William R. Bishop, Supervisory Hearings and Information Officer. [FR Doc. 2017–05893 Filed 3–21–17; 4:15 pm] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Bulk Manufacturer of Controlled Substances Registration ACTION: Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as bulk manufacturers of various classes of controlled substances. SUPPLEMENTARY INFORMATION: The companies listed below applied to be registered as manufacturers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted for these notices. SUMMARY: Company FR docket sradovich on DSK3GMQ082PROD with NOTICES Noramco, Inc ................................................................................................................................................. Isosciences .................................................................................................................................................... AMRI Rensselaer, Inc ................................................................................................................................... Halo Pharmaceutical, Inc .............................................................................................................................. AMPAC Fine Chemicals LLC ........................................................................................................................ Insys Manufacturing LLC .............................................................................................................................. Patheon API Manufacturing, Inc ................................................................................................................... Euticals Inc .................................................................................................................................................... Nanosyn, Inc ................................................................................................................................................. Cerilliant Corporation ..................................................................................................................................... Research Triangle Institute ........................................................................................................................... Synthcon LLC ................................................................................................................................................ Navinta LLC ................................................................................................................................................... Johnson Matthey, Inc .................................................................................................................................... AMRI Rensselaer, Inc ................................................................................................................................... Cayman Chemical Company ........................................................................................................................ Cambridge Isotope Laboratories ................................................................................................................... Janssen Pharmaceutical, Inc ........................................................................................................................ The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of these registrants to manufacture the applicable basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each of the company’s maintenance of effective controls against diversion by inspecting and testing each company’s physical security systems, verifying each company’s compliance with state and local laws, and reviewing each company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR VerDate Sep<11>2014 17:13 Mar 22, 2017 Jkt 241001 Notice of registration. 1301.33, the DEA has granted a registration as a bulk manufacturer to the above listed persons. 81 81 81 81 81 81 81 81 81 81 81 81 81 81 81 81 81 81 FR FR FR FR FR FR FR FR FR FR FR FR FR FR FR FR FR FR 57936 61249 61250 63220 63222 63221 64509 64510 64949 66079 91948 95641 95640 95647 95639 95644 95644 96045 Published August 24, 2016. September 6, 2016. September 6, 2016. September 14, 2016. September 14, 2016. September 14, 2016. September 20, 2016. September 20, 2016. September 21, 2016. September 26, 2016. December 19, 2016. December 28, 2016. December 28, 2016. December 28, 2016. December 28, 2016. December 28, 2016. December 28, 2016. December 29, 2016. Dated: March 17, 2017. Louis J. Milione, Assistant Administrator. Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of various classes of schedule I or II controlled substances. [FR Doc. 2017–05727 Filed 3–22–17; 8:45 am] SUPPLEMENTARY INFORMATION: BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Registration ACTION: PO 00000 SUMMARY: The companies listed below applied to be registered as importers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices. Notice of registration. Frm 00049 Fmt 4703 Sfmt 4703 E:\FR\FM\23MRN1.SGM 23MRN1 14914 Federal Register / Vol. 82, No. 55 / Thursday, March 23, 2017 / Notices Company FR docket Fisher Clinical Services, Inc .......................................................................................................................... Sigma-Aldrich International: GMBH-Sigma Aldrich Company LLC ..................................................................................................... Fisher Clinical Services, Inc ................................................................................................................... Anderson Brecon, Inc ............................................................................................................................ Johnson Matthey Inc .............................................................................................................................. Wildlife Laboratories, Inc ........................................................................................................................ Noramco, Inc .......................................................................................................................................... Mylan Technologies, Inc ........................................................................................................................ 81 FR 61248 September 6, 2016. 81 81 81 81 81 81 82 September 14, 2016. October 4, 2016. October 18, 2016. October 18, 2016. December 28, 2016. December 28, 2016. January 23, 2017. The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each company’s maintenance of effective controls against diversion by inspecting and testing each company’s physical security systems, verifying each company’s compliance with state and local laws, and reviewing each company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I or II controlled substances to the above listed persons. Dated: March 17, 2017. Louis J. Milione, Assistant Administrator. [FR Doc. 2017–05730 Filed 3–22–17; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Application: Wildlife Laboratories, Inc. ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before April 24, 2017. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before April 24, 2017. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette DATES: FR FR FR FR FR FR FR 63223 68455 71766 71766 95644 95640 7859 Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on February 2, 2017, Wildlife Laboratories, Inc., 1230 W. Ash Street, Suite D, Windsor, Colorado 80550–8055 applied to be registered as an importer of the following basic classes of controlled substances: SUPPLEMENTARY INFORMATION: Controlled substance Drug code Etorphine (except HCl) ............................................................................................................................................ Etorphine HCl .......................................................................................................................................................... Thiafentanil .............................................................................................................................................................. sradovich on DSK3GMQ082PROD with NOTICES The company plans to import the listed controlled substances for sale to its customers. DEPARTMENT OF LABOR Dated: March 17, 2017. Louis J. Milione, Assistant Administrator. Agency Information Collection Activities; Submission for OMB Review; Comment Request; FederalState Unemployment Insurance Program Data Exchange Standardization [FR Doc. 2017–05729 Filed 3–22–17; 8:45 am] BILLING CODE 4410–09–P Office of the Secretary ACTION: Notice. 18:27 Mar 22, 2017 Jkt 241001 PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 Schedule 9056 9059 9729 I II II and Training Administration (ETA) sponsored information collection request (ICR) titled, ‘‘Federal-State Unemployment Insurance Program Data Exchange Standardization,’’ to the Office of Management and Budget (OMB) for review and approval for continued use, without change, in accordance with the Paperwork Reduction Act of 1995 (PRA). Public comments on the ICR are invited. The OMB will consider all written comments that agency receives on or before April 24, 2017. DATES: The Department of Labor (DOL) is submitting the Employment SUMMARY: VerDate Sep<11>2014 Published E:\FR\FM\23MRN1.SGM 23MRN1

Agencies

[Federal Register Volume 82, Number 55 (Thursday, March 23, 2017)]
[Notices]
[Pages 14913-14914]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-05730]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Registrants listed below have applied for and been granted 
registration by the Drug Enforcement Administration (DEA) as importers 
of various classes of schedule I or II controlled substances.

SUPPLEMENTARY INFORMATION: The companies listed below applied to be 
registered as importers of various basic classes of controlled 
substances. Information on previously published notices is listed in 
the table below. No comments or objections were submitted and no 
requests for hearing were submitted for these notices.

[[Page 14914]]



----------------------------------------------------------------------------------------------------------------
                 Company                             FR docket                           Published
----------------------------------------------------------------------------------------------------------------
Fisher Clinical Services, Inc............  81 FR 61248                    September 6, 2016.
Sigma-Aldrich International:                                              ......................................
    GMBH-Sigma Aldrich Company LLC.......  81 FR 63223                    September 14, 2016.
    Fisher Clinical Services, Inc........  81 FR 68455                    October 4, 2016.
    Anderson Brecon, Inc.................  81 FR 71766                    October 18, 2016.
    Johnson Matthey Inc..................  81 FR 71766                    October 18, 2016.
    Wildlife Laboratories, Inc...........  81 FR 95644                    December 28, 2016.
    Noramco, Inc.........................  81 FR 95640                    December 28, 2016.
    Mylan Technologies, Inc..............  82 FR 7859                     January 23, 2017.
----------------------------------------------------------------------------------------------------------------

    The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 
958(a) and determined that the registration of the listed registrants 
to import the applicable basic classes of schedule I or II controlled 
substances is consistent with the public interest and with United 
States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. The DEA investigated each company's 
maintenance of effective controls against diversion by inspecting and 
testing each company's physical security systems, verifying each 
company's compliance with state and local laws, and reviewing each 
company's background and history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the DEA has granted a registration as 
an importer for schedule I or II controlled substances to the above 
listed persons.

    Dated: March 17, 2017.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2017-05730 Filed 3-22-17; 8:45 am]
 BILLING CODE 4410-09-P